Oxford BioMedica (FRA:OXOA) Moat Score : 6/10 (As of Jul. 08, 2025)

View and export this data going back to . Start your Free Trial

What is Oxford BioMedica Moat Score?

Oxford BioMedica has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Oxford BioMedica has Narrow Moat: Oxford BioMedica has a strong narrow moat with valuable IP in gene and cell therapy, significant R&D capabilities, and strategic partnerships. However, it does not yet have the market dominance for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Oxford BioMedica might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Competitive Comparison of Oxford BioMedica's Moat Score

For the Biotechnology subindustry, Oxford BioMedica's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioMedica's Moat Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioMedica's Moat Score distribution charts can be found below:

* The bar in red indicates where Oxford BioMedica's Moat Score falls into.

Save Embed

;

Save Embed

;

Oxford BioMedica (FRA:OXOA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score	Moat Level
10	Wide Moat - Exceptionally dominant and durable wide moat
8 - 9	Wide Moat - Clear and robust wide moat
7	Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6	Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5	Narrow Moat - Solid narrow moat
4	Narrow Moat - Discernible but modest moat
1 - 3	No Moat - Very weak/transient advantages
0	No Moat - No discernible moat

Oxford BioMedica Moat Score Related Terms

Thank you for viewing the detailed overview of Oxford BioMedica's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioMedica Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (FRA:OXOA) » Definitions » Moat Score

Comparable Companies

Traded in Other Exchanges

OXBDF:USA OXBl:UK OXB:UK

Address

Windrush Court, Transport Way, Oxford, GBR, OX4 6LT

Website

https://www.oxb.com

Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types.

Oxford BioMedica Headlines

No Headlines